Cargando…
Targeting Oncometabolism to Maximize Immunotherapy in Malignant Brain Tumors
Brain tumors result in significant morbidity and mortality in both children and adults. Recent data indicates that immunotherapies may offer a survival benefit after standard of care has failed for malignant brain tumors. Modest results from several late phase clinical trials, however, underscore th...
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081266/ https://www.ncbi.nlm.nih.gov/pubmed/35430605 http://dx.doi.org/10.1038/s41388-022-02312-y |